Artal Group S.A. - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 160 filers reported holding ARRAY BIOPHARMA INC in Q3 2015. The put-call ratio across all filers is 1.26 and the average weighting 0.2%.

Quarter-by-quarter ownership
Artal Group S.A. ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q1 2019$48,760,000
+36.9%
2,000,000
-20.0%
1.99%
+50.9%
Q4 2018$35,625,000
+23.4%
2,500,000
+31.6%
1.32%
+75.6%
Q3 2018$28,880,000
-13.9%
1,900,000
-5.0%
0.75%
+5.3%
Q2 2018$33,560,000
+2.8%
2,000,0000.0%0.71%
+74.8%
Q1 2018$32,640,000
+27.5%
2,000,0000.0%0.41%
+5.4%
Q4 2017$25,600,000
-16.7%
2,000,000
-20.0%
0.39%
-27.0%
Q3 2017$30,750,000
+153.4%
2,500,000
+72.4%
0.53%
+150.0%
Q2 2017$12,137,000
+81.0%
1,450,000
+93.3%
0.21%
+42.3%
Q1 2017$6,705,000
-39.0%
750,000
-40.0%
0.15%
-38.9%
Q4 2016$10,988,000
-53.5%
1,250,000
-64.3%
0.24%
-47.9%
Q3 2016$23,625,000
+71.5%
3,500,000
-9.6%
0.47%
+64.8%
Q2 2016$13,777,000
+25.9%
3,870,000
+4.3%
0.28%
+32.7%
Q1 2016$10,945,000
-35.3%
3,710,000
-7.5%
0.21%
-32.7%
Q4 2015$16,922,000
-7.5%
4,010,0000.0%0.32%
-22.2%
Q3 2015$18,286,000
-36.8%
4,010,0000.0%0.41%
-67.1%
Q2 2015$28,912,000
+5.7%
4,010,000
+8.1%
1.24%
-1.6%
Q1 2015$27,343,000
+74.6%
3,710,000
+12.1%
1.26%
+130.2%
Q4 2014$15,656,000
+46.2%
3,310,000
+10.3%
0.55%
+39.3%
Q3 2014$10,710,000
-21.7%
3,000,0000.0%0.39%
-28.8%
Q2 2014$13,680,000
-3.0%
3,000,0000.0%0.55%
+8.4%
Q1 2014$14,100,000
-6.2%
3,000,0000.0%0.51%
-5.4%
Q4 2013$15,030,000
-19.5%
3,000,0000.0%0.54%
-11.2%
Q3 2013$18,660,000
+37.0%
3,000,0000.0%0.61%
+41.5%
Q2 2013$13,620,0003,000,0000.43%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q3 2015
NameSharesValueWeighting ↓
Advisory Services Network, LLC 3,442$159,0000.01%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ARRAY BIOPHARMA INC shareholders